Business | Sunday November 23, 2014
In a suspected case of round tripping through a web of cryptic deals running across India, Hong Kong and Switzerland, the Securities and Exchange Board of India (Sebi) has ordered a detailed probe into the alleged diversion of funds raised by pharmaceuticals company Transgene Biotek through issuance of global depository receipts (GDRs).
www.ndtv.com/business